Just a reminder that the revised client forms implement today! Don't forget to toss your old versions! If you need a refresher on what forms are impacted, you can read about it here: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...